Hospital-acquired Infections Clinical Trial
Official title:
Impact of Gender on Infected Hospitalized Patients
NCT number | NCT00170560 |
Other study ID # | 01-337 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | October 2001 |
Verified date | October 2007 |
Source | National Institute of Allergy and Infectious Diseases (NIAID) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The purpose of this study is to better understand the relationship between gender (being a man or a woman), infections caught in the hospital, and serious illness. Five hundred seventy patients 18 years of age or older who are critically (seriously) ill and admitted to the Intensive Care Unit (ICU) for at least 48 hours will participate in this study. Patients will be studied while receiving regular ICU treatment according to local standards. Blood specimens will come from patients either as wasted blood (University of Virginia) or blood collected from patients specifically for the study (Vanderbilt University). All patients will be followed daily until death or discharge from the ICU. The researchers believe that they will find a similar risk of infection for men and women overall.
Status | Completed |
Enrollment | 635 |
Est. completion date | |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 99 Years |
Eligibility |
Inclusion Criteria: 1. All patients >= 18 years old admitted to the ICU for >= 48 hours. Exclusion Criteria: 1. Age < 18 years old. 2. Death or discharge within 48 hours of ICU admission. 3. Patients not on a surgical service. 4. Patients admitted with a primary diagnosis of burns. |
Country | Name | City | State |
---|---|---|---|
United States | University of Virginia | Charlottesville | Virginia |
United States | Vanderbilt University | Nashville | Tennessee |
Lead Sponsor | Collaborator |
---|---|
National Institute of Allergy and Infectious Diseases (NIAID) |
United States,
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03411538 -
Mortality Related to AMR in Patients With Hospital-acquired Infection
|
||
Not yet recruiting |
NCT05201560 -
Efficacy and Safety of Butorphanol Tartrate Injection for the Patients With Mechanical Ventilation
|
N/A | |
Recruiting |
NCT05547373 -
Infection Prevention and Control Intervention to Reduce Hospital-acquired Infections
|
N/A |